Efficacy of topical clobetasol propionate in the treatment of idiopathic granulomatous mastitis

Yıl 2018, Cilt: 31 Sayı: 3, 108 - 111, 31.10.2018

Züleyha Yazıcı Özgen Elif Cömert Mustafa Ümit Uğurlu

https://doi.org/10.5472/marumj.474170

Öz

Objectives: To evaluate the efficacy of topical clobetasol

propionate 0.05% pomade in the treatment of idiopathic

granulomatous mastitis.

Patients and Methods: Twenty-one idiopathic granulomatous

mastitis patients’ clinical and histopathological findings were

retrospectively reviewed. Those patients excluded from other

etiologies were categorized as idiopathic granulomatous mastitis

and treated with topical clobetasol propionate 0.05% pomade as

an initial treatment.

Results: All 21 patients with a final diagnosis of idiopathic

granulomatous mastitis were women with the average age of

36.2+/-5.2 years. Of the 21 patients; erythema, induration and pain

problems of 6 (28.5%) patients totally resolved without recurrence

in 3 months follow-up period. Erythema, induration and pain

problems of 7 (33.5%) patients were minimalized and stay stable

in 3 months follow-up period. The symptoms of 8 (38%) did not

change under topical clobetasol propionate treatment. None of the

patients developed side or adverse effects due to topical steroid

treatment and 6 of 18 patients with non-steroidal anti-inflammatory

drugs (NSAIDs) complained of gastric pain.

Conclusion:Topical steroid treatment is a safe treatment option

for idiopathic granulomatous mastitis patients before systemic

steroid and immunosuppressive treatments and also surgery.

Anahtar Kelimeler

Idiopathic granulomatous mastitis, Granulomatous mastitis, Mastitis, Topical Steroid, Steroid

İdiyopatik granülomatöz mastit tedavisinde yerel klobetazol propionatın etkinliği

Öz

Amaç: İdiyopatik granulomatöz mastit tedavisinde topikal

klobetazol propiyonat %0,05 pomadın etkinliğini değerlendirmek.

Hastalar ve Yöntemler: Klinik ve histopatolojik olarak

idiyopatik granülomatöz mastit tanısı konulan 21 hastanın

dosyası retrospektif olarak incelendi. Altta yatan başka patoloji

saptanmayan hastalar idiyopatik granülomatöz mastit olarak

sınıflandırıldı ve ilk tedavi olarak topikal klobetazol propiyonat %

0,05 pomad uygulandı.

Bulgular: İdiyopatik granülomatöz mastit tanılı 21 kadın

hastanın yaş ortalaması 36,2 ± 5,2 yıldı. Yirmi bir hastanın 6 (%

28,5)’sının eritem, sertlik ve ağrı problemleri tamamen geriledi ve

3 aylık takip döneminde tekrarlamadı. Hastaların 7 (% 33,5)’sinde

eritem, sertlik ve ağrı şikayetleri tama yakın geriledi ve 3 ay

süreli takiplerinde artış izlenmedi. Sekiz (%38) hastada iyileşme

gözlenmedi. Hastalarda yerel steroid tedavisine bağlı yan etki

görülmezken, ek olarak non-steroid antiinflamatuvar (NSAI) ilaç

kullanan 18 hastanın 6’sında mide ağrısı şikayetleri gelişti.

Sonuç: Yerel steroid tedavileri idiyopatik granülomatöz mastit

tedavisinde etkili ve güvenli tedavi seçenekleridir.

Anahtar Kelimeler

İdiyopatik granülomatöz mastit, Granülomatöz mastit, Mastit, Yerel steroid, Steroid

Kaynakça

• 1. Baslaim MM, Khayat HA, Al-Amoudi SA. Idiopathic granulomatous mastitis: a heterogenous disease with variable clinical presentations. World J Surg 2007; 31:1677-81. doi: 10.1007/s00268-007-9116-1
• 2. Ocal K, Dag A, Turkmenoglu O, et al. Granulomatous mastitis: Clinical, pathological features and management. Breast J 2010; 16: 176-82. doi: 10.1111/j.1524-4741.2009.00879.x
• 3. Yılmaz TU, Gürel B, Güler SA, et al. Scoring idiopathic granulomatous mastitis: an effective system for predicting recurrence? Eur J Breast Health 2018; 14:112-16. doi: 10.5152/ejbh.2018.3709
• 4. Benson JR, Dumitru D. Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncol 2016;12: 1381-94. doi: 10.2217/fon-2015-0038
• 5. Al-khaaf B, Knox F, Bundred NJ. Idiopathic granulomatous mastitis: a 25-year experince. J Am Coll Surg 2008; 206: 269-73. doi: 10.1016/j.jamcollsurg.2007.07.041
• 6. Azlina AF, Ariza Z, Arni T, et al. Chronic granulomatous mastitis: diagnostic and therapeutic considerations. World J Surg 2003; 27: 515 – 18. doi: 10.1007/s00268-003-6806-1
• 7. Moris D, Damaskos C, Davakis S, et al. Is idiopathic granulomatous mastitis a surgical disease? The jury is still out. Ann Transl Med 2017;5:309-13. doi: 10.21037/ atm.2017.05.24
• 8. Kieffer P, Dukic R, Huiber M, et al. A young woman with granulomatous mastitis: a corynebacteria may be involved in the pathogenesis of this disease. Rev Med Intern 2006; 27: 550-4. doi: 10.1016/j.revmed.2006.03.033
• 9. Cserni G, Szajki K. Granulomatous lobuler mastitis following drug-induced galactorrhea and blunt trauma. Breast J 1999;5:398-403.
• 10. Lei X, Chen K, Zhu L, et al. Treatment for idiopathic granulomatous mastitis: systematic review and metaanalysis. Breastfeed Med 2017; 12:415-21. doi: 10.1089/ bfm.2017.0030
• 11. Gumus M, Akkurt ZM, Gumus H. Is erythema nodosum coexisting with lesions of the breast a suggestive sign for idiopathic granulomatous mastitis? Turk J Surg 2018; 34:71- 3. doi: 10.5152/turkjsurg.2017.3161
• 12. DeHertogh DA, Rossof AH, Harris AA. et al. Prednisone management of granulomatous mastitis. N Engl J Med 1980; 303:799-800. doi: 10.1056/NEJM198010023031406
• 13. Altıntoprak F. Topical steroids to treat granulomatous mastitis: A case report. Korean J Intern Med 2011; 26:356-9. doi: 10.3904/kjim.2011.26.3.356
• 14. Gunduz Y, Antıntoprak F, Ayhan LT, et al. Effect of topical steroid treatment on Idiopathic Granulomatous Mastitis: clinical and radiological evaluation. The Breast J 2014;20:586-91. doi: 10.1111/tbj.12335
• 15. Altıntoprak F, Kıvılcım, Yalkın O, et al. Topical steroids are effective in the treatment of Idiopathic Granulomatous mastitis. World J Surg 2015;39: 2718-23. doi: 10.1007/ s00268-015-3147-9
• 16. Pandey TS, Mackinnon JC, Bressler L, et al. Idiopathic granulomatous mastitis-a prospective study of 49 woman and treatment outcomes with steroid therapy. Breast J 2014; 20:258-66. doi: 10.1111/tbj.12263
• 17. Bouton ME, Jayaram L, O’Neill PJ, et al. Management of idiopathic granulomatous mastitis with observation. Am J Surg 2015; 210: 258-62. doi:10.1016/j.amjsurg.2014.08.044
• 18. Mahlab-Guri K, Asher I, Allweis T, et al. Granulomatous lobular mastitis. Isr Med Assoc J 2015; 17:476-80.
• 19. Hur SM, Cho DH, Lee SK, et al. Experience of treatment of patients with granulomatous lobular mastitis. J Korean Surg Soc 2013;85:1-6. doi: 10.4174/jkss.2013.85.1.1